Cantor Fitzgerald analyst Li Watsek reiterated an Overweight rating on Sensei Biotherapeutics (NASDAQ: SNSE).The analyst commented, "Following our initiation of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE